Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Metzger

Showing results (161-170 of 185) with videos related to

Pageof 19
Sort By:
Tissue Antigens|February 3, 2006
Monoclonal antibodies to native mouse angiotensin-converting enzyme (CD143): ACE expression quantification, lung endothelial cell targeting and gene deliveryI V Balyasnikova, Z-L Sun, R Metzger, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 2, 1998
p53 point mutations and thymidylate synthase messenger RNA levels in disseminated colorectal cancer: an analysis of response and survivalH J Lenz, K Hayashi, D Salonga, et al.
The Pharmacogenomics Journal|March 11, 2009
GNAS1 T393C polymorphism is associated with histopathological response to neoadjuvant radiochemotherapy in esophageal cancerH Alakus, U Warnecke-Eberz, E Bollschweiler, et al.
Oncogene|October 23, 1997
High frequency of simultaneous loss of p16 and p16beta gene expression in squamous cell carcinoma of the esophagus but not in adenocarcinoma of the esophagus or stomachK Hayashi, R Metzger, D Salonga, et al.
Journal of Surgical Oncology|August 5, 2009
Lack of prognostic significance of serum DNA methylation of DAPK, MGMT, and GSTPI in patients with non-small cell lung cancerA C Hoffmann, J T Kaifi, D Vallböhmer, et al.
Der Pathologe|May 29, 2004
[Regression of oesophageal carcinomas after neoadjuvant radiochemotherapy: criteria of the histopathological evaluation]S E Baldus, S P Mönig, W Schröder, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 25, 2000
Colorectal tumors responding to 5-fluorouracil have low gene expression levels of dihydropyrimidine dehydrogenase, thymidylate synthase, and thymidine phosphorylaseD Salonga, K D Danenberg, M Johnson, et al.
Histopathology|January 16, 2007
Association of COX-2 expression with corresponding active and chronic inflammatory reactions in Barrett's metaplasia and progression to cancerF C Ling, S E Baldus, J Khochfar, et al.
British Journal of Cancer|June 24, 2004
Quantitative c-erbB-2 but not c-erbB-1 mRNA expression is a promising marker to predict minor histopathologic response to neoadjuvant radiochemotherapy in oesophageal cancerF Miyazono, R Metzger, U Warnecke-Eberz, et al.
Cancer Letters|October 6, 1997
Thymidylate synthase is a predictor for response and resistance in hepatic artery infusion chemotherapyM Kornmann, K H Link, H J Lenz, et al.
Pageof 19

Showing results (161-170 of 185) with videos related to

Sort By:
Pageof 19
Tissue Antigens|February 3, 2006
Monoclonal antibodies to native mouse angiotensin-converting enzyme (CD143): ACE expression quantification, lung endothelial cell targeting and gene deliveryI V Balyasnikova, Z-L Sun, R Metzger, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 2, 1998
p53 point mutations and thymidylate synthase messenger RNA levels in disseminated colorectal cancer: an analysis of response and survivalH J Lenz, K Hayashi, D Salonga, et al.
The Pharmacogenomics Journal|March 11, 2009
GNAS1 T393C polymorphism is associated with histopathological response to neoadjuvant radiochemotherapy in esophageal cancerH Alakus, U Warnecke-Eberz, E Bollschweiler, et al.
Oncogene|October 23, 1997
High frequency of simultaneous loss of p16 and p16beta gene expression in squamous cell carcinoma of the esophagus but not in adenocarcinoma of the esophagus or stomachK Hayashi, R Metzger, D Salonga, et al.
Journal of Surgical Oncology|August 5, 2009
Lack of prognostic significance of serum DNA methylation of DAPK, MGMT, and GSTPI in patients with non-small cell lung cancerA C Hoffmann, J T Kaifi, D Vallböhmer, et al.
Der Pathologe|May 29, 2004
[Regression of oesophageal carcinomas after neoadjuvant radiochemotherapy: criteria of the histopathological evaluation]S E Baldus, S P Mönig, W Schröder, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 25, 2000
Colorectal tumors responding to 5-fluorouracil have low gene expression levels of dihydropyrimidine dehydrogenase, thymidylate synthase, and thymidine phosphorylaseD Salonga, K D Danenberg, M Johnson, et al.
Histopathology|January 16, 2007
Association of COX-2 expression with corresponding active and chronic inflammatory reactions in Barrett's metaplasia and progression to cancerF C Ling, S E Baldus, J Khochfar, et al.
British Journal of Cancer|June 24, 2004
Quantitative c-erbB-2 but not c-erbB-1 mRNA expression is a promising marker to predict minor histopathologic response to neoadjuvant radiochemotherapy in oesophageal cancerF Miyazono, R Metzger, U Warnecke-Eberz, et al.
Cancer Letters|October 6, 1997
Thymidylate synthase is a predictor for response and resistance in hepatic artery infusion chemotherapyM Kornmann, K H Link, H J Lenz, et al.
Pageof 19